An innovative experimental treatment for boosting the effectiveness of stem - cell
transplants with
umbilical cord blood has a favorable safety profile in long - term animal studies, report scientists
from Dana - Farber Cancer Institute, Beth Israel Deaconess Medical Center (BIDMC), and Children's Hospital Boston (CHB).